(Q33451352)

English

Melanoma and immunotherapy

scientific article

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

26 July 2017

1 reference

Europe PubMed Central

title

Melanoma and immunotherapy (English)

1 reference

stated in

Europe PubMed Central

26 July 2017

1 reference

1

Alexander M M Eggermont

1 reference

stated in

Europe PubMed Central

26 July 2017

2

Dirk Schadendorf

1 reference

stated in

Europe PubMed Central

26 July 2017

1 June 2009

1 reference

stated in

Europe PubMed Central

26 July 2017

Hematology / Oncology Clinics of North America

1 reference

stated in

Europe PubMed Central

26 July 2017

23

1 reference

stated in

Europe PubMed Central

26 July 2017

547-64, ix-x

1 reference

stated in

Europe PubMed Central

26 July 2017

3

1 reference

stated in

Europe PubMed Central

26 July 2017

Results of a phase II clinical trial of 2 doses and schedules of CP-675,206, an anti-CTLA4 monoclonal antibody, in patients (pts) with advanced melanoma

1 reference

18 October 2022

https://opencitations.net/index/coci/api/v1/citations/10.1200/JCO.2007.25.18_SUPPL.3000

Identifiers

DOI

10.1016/J.HOC.2009.03.009

1 reference

stated in

Europe PubMed Central

26 July 2017

1 reference

Europe PubMed Central

PubMed ID

19464602

retrieved

26 July 2017

ResearchGate publication ID

26236219

0 references

(Q33451352)

Melanoma and immunotherapy

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)